Jana M. Vidal Teuton

Leiden University Medical Center

Papers

2

Total Citations

7

H-Index

2

About

Jana M. Vidal Teuton is a pioneering researcher at the intersection of cancer biology and biomedical engineering, whose work is revolutionizing preclinical drug testing. Her primary research focus is the development of automated microinjection systems for zebrafish xenograft models—a cutting-edge approach that uses zebrafish larvae engrafted with human cancer cells to predict patient-specific responses to therapeutics. Her most-cited paper, "Automated microinjection for zebrafish xenograft models" (2025, 5 citations), addresses a critical bottleneck in the field: the labor-intensive, manual microinjection of cancer cells into fragile larvae. By automating this process, Vidal Teuton enhances reproducibility and throughput, moving zebrafish xenografts closer to routine clinical use as diagnostic tools. Her follow-up work (2024, 2 citations) further refines these techniques, underscoring her commitment to translating animal models into practical, high-impact solutions. With a combined citation count of 7 for her foundational papers, her contributions are gaining traction among cancer researchers and bioengineers alike. Vidal Teuton’s innovations promise to accelerate personalized medicine, making her a rising star in the field of translational oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
7
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Automated microinjection for zebrafish xenograft models
5 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Leiden University Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago